240 related articles for article (PubMed ID: 34311143)
1. Cellular and molecular regulation of the programmed death-1/programmed death ligand system and its role in multiple sclerosis and other autoimmune diseases.
Ibañez-Vega J; Vilchez C; Jimenez K; Guevara C; Burgos PI; Naves R
J Autoimmun; 2021 Sep; 123():102702. PubMed ID: 34311143
[TBL] [Abstract][Full Text] [Related]
2. The PD-1/PD-Ls pathway is up-regulated during the suppression of experimental autoimmune encephalomyelitis treated by Astragalus polysaccharides.
Sun Y; Jing Y; Huang M; Ma J; Peng X; Wang J; Li G; Cheng X
J Neuroimmunol; 2019 Jul; 332():78-90. PubMed ID: 30981049
[TBL] [Abstract][Full Text] [Related]
3. Interferon-γ/Interleukin-27 Axis Induces Programmed Death Ligand 1 Expression in Monocyte-Derived Dendritic Cells and Restores Immune Tolerance in Central Nervous System Autoimmunity.
Casella G; Rasouli J; Thome R; Descamps HC; Vattikonda A; Ishikawa L; Boehm A; Hwang D; Zhang W; Xiao D; Park J; Zhang GX; Alvarez JI; Rostami A; Ciric B
Front Immunol; 2020; 11():576752. PubMed ID: 33193372
[TBL] [Abstract][Full Text] [Related]
4. Role of the PD-1/PD-L1 Signaling in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Recent Insights and Future Directions.
Mi Y; Han J; Zhu J; Jin T
Mol Neurobiol; 2021 Dec; 58(12):6249-6271. PubMed ID: 34480337
[TBL] [Abstract][Full Text] [Related]
5. The Diverse Function of PD-1/PD-L Pathway Beyond Cancer.
Qin W; Hu L; Zhang X; Jiang S; Li J; Zhang Z; Wang X
Front Immunol; 2019; 10():2298. PubMed ID: 31636634
[TBL] [Abstract][Full Text] [Related]
6. Human brain endothelial cells endeavor to immunoregulate CD8 T cells via PD-1 ligand expression in multiple sclerosis.
Pittet CL; Newcombe J; Prat A; Arbour N
J Neuroinflammation; 2011 Nov; 8():155. PubMed ID: 22067141
[TBL] [Abstract][Full Text] [Related]
7. Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis.
Zhu B; Guleria I; Khosroshahi A; Chitnis T; Imitola J; Azuma M; Yagita H; Sayegh MH; Khoury SJ
J Immunol; 2006 Mar; 176(6):3480-9. PubMed ID: 16517716
[TBL] [Abstract][Full Text] [Related]
8. The change of PD1, PDL1 in experimental autoimmune encephalomyelitis treated by 1,25(OH)
Cao Q; Zheng C; Xie Z; Liu L; Zhu J; Jin T
J Neuroimmunol; 2020 Jan; 338():577079. PubMed ID: 31731230
[TBL] [Abstract][Full Text] [Related]
9. The PD-1/PD-Ls pathway and autoimmune diseases.
Dai S; Jia R; Zhang X; Fang Q; Huang L
Cell Immunol; 2014 Jul; 290(1):72-9. PubMed ID: 24908630
[TBL] [Abstract][Full Text] [Related]
10. Granulocytic myeloid-derived suppressor cells inhibit T follicular helper cells during experimental Schistosoma japonicum infection.
Zhang Y; Wu Y; Liu H; Gong W; Hu Y; Shen Y; Cao J
Parasit Vectors; 2021 Sep; 14(1):497. PubMed ID: 34565440
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cell upregulation of programmed death ligand-1 via DNA demethylation inhibits experimental autoimmune encephalomyelitis.
Chang CB; Lee SP; Chen WM; Wang CM; Song YC; Chan MW; Wu SF
J Autoimmun; 2020 Feb; 107():102362. PubMed ID: 31787479
[TBL] [Abstract][Full Text] [Related]
12. PD-1 ligands expressed on myeloid-derived APC in the CNS regulate T-cell responses in EAE.
Schreiner B; Bailey SL; Shin T; Chen L; Miller SD
Eur J Immunol; 2008 Oct; 38(10):2706-17. PubMed ID: 18825752
[TBL] [Abstract][Full Text] [Related]
13. Soluble programmed cell death protein 1 (sPD-1) and the soluble programmed cell death ligands 1 and 2 (sPD-L1 and sPD-L2) in lymphoid malignancies.
Mortensen JB; Monrad I; Enemark MB; Ludvigsen M; Kamper P; Bjerre M; d'Amore F
Eur J Haematol; 2021 Jul; 107(1):81-91. PubMed ID: 33721375
[TBL] [Abstract][Full Text] [Related]
14. Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity.
Gianchecchi E; Delfino DV; Fierabracci A
Autoimmun Rev; 2013 Sep; 12(11):1091-100. PubMed ID: 23792703
[TBL] [Abstract][Full Text] [Related]
15. Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality.
Saha A; Aoyama K; Taylor PA; Koehn BH; Veenstra RG; Panoskaltsis-Mortari A; Munn DH; Murphy WJ; Azuma M; Yagita H; Fife BT; Sayegh MH; Najafian N; Socie G; Ahmed R; Freeman GJ; Sharpe AH; Blazar BR
Blood; 2013 Oct; 122(17):3062-73. PubMed ID: 24030385
[TBL] [Abstract][Full Text] [Related]
16. Follicular Helper CD4
Zhang X; Ge R; Chen H; Ahiafor M; Liu B; Chen J; Fan X
Mediators Inflamm; 2021; 2021():2058964. PubMed ID: 34552387
[TBL] [Abstract][Full Text] [Related]
17. Structure and interactions of the human programmed cell death 1 receptor.
Cheng X; Veverka V; Radhakrishnan A; Waters LC; Muskett FW; Morgan SH; Huo J; Yu C; Evans EJ; Leslie AJ; Griffiths M; Stubberfield C; Griffin R; Henry AJ; Jansson A; Ladbury JE; Ikemizu S; Carr MD; Davis SJ
J Biol Chem; 2013 Apr; 288(17):11771-85. PubMed ID: 23417675
[TBL] [Abstract][Full Text] [Related]
18. Targeting the programmed death-1 pathway in lymphoid neoplasms.
Ok CY; Young KH
Cancer Treat Rev; 2017 Mar; 54():99-109. PubMed ID: 28242522
[TBL] [Abstract][Full Text] [Related]
19. B7-H1 Selectively Controls TH17 Differentiation and Central Nervous System Autoimmunity via a Novel Non-PD-1-Mediated Pathway.
Herold M; Posevitz V; Chudyka D; Hucke S; Groß C; Kurth F; Leder C; Loser K; Kurts C; Knolle P; Klotz L; Wiendl H
J Immunol; 2015 Oct; 195(8):3584-95. PubMed ID: 26378076
[TBL] [Abstract][Full Text] [Related]
20. Programmed cell death 1 (PD-1) regulates the effector function of CD8 T cells via PD-L1 expressed on target keratinocytes.
Okiyama N; Katz SI
J Autoimmun; 2014 Sep; 53():1-9. PubMed ID: 25047812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
